Eledon Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Eledon Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Eledon Pharmaceuticals Inc
Rating: 1.82975
Author: Trendlyne DVM scores

about

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis...

3.95 0.07 (1.80%)

192.59% Gain from 52W Low

2.0M

XNAS Volume

XNAS 14 May, 2026 5:30 PM (EDT)

Board Meeting

The latest board meeting for Eledon Pharma Inc took place on 14 May 2026, for the purpose of Eledon Pharmaceuticals Inc First Quarter Earnings Results for 2026 See details

Not Eligible

Expensive Valuation

6.5 / 100

Technically Moderately Bullish

66.7 / 100

No estimates available

Eledon Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Eledon Pharma Inc Live Stock Price Today, Share Analysis and Chart

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis...

192.59% Gain from 52W Low

SWOT Analysis

Eledon Pharma Inc Live Price Chart